Polio Sabin

Description

Polio Sabin™(oral) vaccine is a stabilised preparation of live attenuated poliomyelitis viruses of the Sabin™ strains type 1, 2 and 3, propagated in MRC5 human diploid cells. Polio Sabin™ (oral) is indicated for active immunisation of infants and susceptible children and adults against infection caused by 3 types of wild Polioviruses.

IMMUNIZATION GUIDELINE

Infants:

• The primary immunisation course is three doses of Polio Sabin™ (oral) vaccine

• The vaccine should be administered with an interval of at least one month between doses

Children and adults:

• A booster dose at the time of school entry and occasionally in adult life when a person is likely to be exposed to a high risk of infection, such as when travelling to endemic areas

Polio Sabin™ (oral) is for oral use only. One dose of vaccine (0.1 ml) should be delivered in 2 drops from the polyethylene dropper supplied with the glass vial or directly from the plastic tube.

For Immunization schedule as per IAP guidelines see OPV Immunization schedule

Additional information

manufacturer

GlaxoSmithKline

country-of-manufacture

Belgium

pharmaceutical-form

Liquid

package-size

10 Dose

route-of-administration

Oral

preservative

None

Contraindications

Polio Sabin™ (oral) should not be given to children with known hypersensitivity to neomycin or polymyxin or to any other component of the vaccine. Immunodeficiency is also a contraindication, inactivated polio vaccine (IPV) should be alternatively administered.